A Randomized, Double-Blind (3rd Party Open), Double-Dummy, Placebo- And Active Controlled, 3-Way Crossover Study To Determine The Effects Of Oral PF-03893787 On Allergen-Induced Airway Responses In Mild Asthmatic Subjects.
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2010
At a glance
- Drugs Montelukast; ZPL 3893787
- Indications Asthma
- Focus Pharmacodynamics
- 23 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jan 2010 Last checked against ClinicalTrials.gov record.
- 01 Jul 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.